与慢性自发性疹相关的亚托皮性并发症:对我们所有人研究计划的病例对照分析
Julian A Cortes1, Nana Ama Adjei-Frimpong1, Savannah K Fakhouri1
1Department of Dermatology University of California, San Diego San Diego California USA.
JEADV clinical practice
|March 11, 2026
概括
慢性自发性疹 (CSU) 与疹和喘等类型疾病密切相关. 这项多元化的研究表明共享的免疫路径,支持针对性治疗患者的两个条件.
科学领域:
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
- 过敏 过敏是一种过敏.
背景情况:
- 慢性自发性疹 (CSU) 是一种由巨细胞介导的疾病,其特征是经常出现疹和/或无已知触发因子的血管.
- 虽然CSU与亚托皮性疾病共享Th2-主导免疫路径,但这些不同人群中的关联仍未得到充分研究.
研究的目的:
- 在多样化的"我们所有人" (AoU) 研究计划中调查CSU和无形共患病之间的关系.
- 在全国范围内对协会进行评估,以增加来自历史上服务不足的群体的代表性.
主要方法:
- 从2018年5月到2023年10月,使用AOU参与者 (年龄≥18岁) 进行了一项匹配的病例控制研究.
- 根据年龄,性别,种族,种族和吸烟状况,CSU病例 (SNOMED代码51611005,42265009) 与对照病例相匹配 4:1.
- 对比了亚托皮性皮肤炎,过敏性鼻炎,喘,鼻,食物过敏和药物过敏的发病率,多变量逻辑回归调整了相关条件.
主要成果:
- 该研究包括1171个CSU病例和4684个匹配的对照,没有显著的人口差异.
- 在CSU患者中,阿托皮性皮炎 (12.6%对1.7%),过敏性鼻炎 (58%对13.2%),喘 (46.2%对13.2%),鼻 (3.8%对0.7%) 和食物/药物过敏 (所有p<0.001) 的患病率显著更高.
- 在多变量调整 (p < 0.001) 后,这些关联仍然显著 (p < 0.001).
结论:
- 在一个多样化的队列中观察到CSU和亚托皮性疾病之间的强烈关联.
- 结果表明共享Th2驱动的免疫路径,支持CSU患者使用2型向治疗的共患性亚托皮.
- 为全面和有针对性的治疗策略,建议查CSU患者的亚托皮性疾病.
相关概念视频
02:06Allergic Reactions
26.4K
Overview
26.4K
01:30Drug Toxicity: Allergic Reactions
209
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
209
01:30Allergic Reactions: Anaphylaxis
280
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
280
01:28Asthma I: Introduction
112
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
112
01:13Asthma III: Clinical Manifestations
49
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
49
01:19Hypersensitivity Reactions: Immune-Complex Reactions
269
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum...
269